Graves病131I治疗后短期内新发甲状腺相关性眼病相关因素分析

《Graves病131I治疗后短期内新发甲状腺相关性眼病相关因素分析》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、分类号：R581.1UDC：密级：重庆医科大学硕士学位论文131Graves病I治疗后论文题目短期内新发甲状腺相关性眼病相关因素分析作者姓名李彦指导教师姓名（职称、单位名称）李启富教授重庆医科大学附属第一医院内分泌科申请学位级别硕士（同等学力）学科、专业名称内科学论文答辩年月2016年04月2016年01月目录英汉缩略语名词对照···················································································1中文摘要··············································

2、····················································2英文摘要··································································································3131论文正文：Greaves’病I治疗后短期内新发甲状腺相关性眼病相关因素分析·······5前言·····························································································

3、·····5第一章、材料与方法···············································································61材料·····························································································61.1研究对象·················································································61.2纳入标准···········

4、·····································································61.3排除标准················································································61.4相关诊断标准··········································································71.5一般资料··················································

5、······························72研究方法·························································································72.1主要仪器、试剂及测定方法·························································72.2研究步骤················································································72.3观察指标·····

6、···········································································82.4统计学方法·············································································9第二章、结果··························································································101一般资料··································

7、·····················································102新发甲状腺相关性眼病临床资料························································103甲状腺相关抗体及TNF-α比较···························································111